Work

CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery

Year: 2016

Type: review

Source: Trends in cancer

DOI: 10.1016/j.trecan.2016.05.001

Author: Ji Luo

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research

Language: English

Topic: CRISPR and Genetic Engineering

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Award: Genetic screens for target discovery in cancer

OpenAlex ID: W2415560311

FWCI: 0.462

Cites: 74

Cited by: 57

Related to: 10